INS and type 2 diabetes mellitus: The reduction of functional insulin‐producing beta cells contributes to the development and progression of T2DM.7, 8 As the nature of this condition is progressive and as beta‐cell activity declines, a glycaemic control and medication regimen should be re‐evaluated routinely and adjusted based on patient characteristics.